Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06395974

Fetal Renal Artery Doppler in Patients With Preeclampsia

Fetal Renal Artery Doppler in Patients With Preeclampsia and Its Role in Prediction of Adverse Neonatal Outcomes

Status
Recruiting
Phase
Study type
Observational
Enrollment
88 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

Detailed description

Preeclampsia is a major devastating medical condition that affects pregnant women after 20 weeks of pregnancy. It affects 2:10% of pregnancies worldwide according to World Health Organisation with higher incidence in developing countries. Vascular endothelial dysfunction due to abnormal placentation is believed to be the main cause of multi-organ failure and uteroplacental insufficiency that occur in preeclampsia leading to major adverse effects in both mother and fetus. Placental insufficiency causes a redistribution of fetal blood to essential organs ; brain, heart and adrenal glands by decreasing their vascular resistance on expense of peripheral organs such as kidney which exhibit increased vascular resistance and impaired perfusion. This is in contrast to normal pregnancies near term in which renal vascular resistance falls and increased blood flow to the kidneys is observed. Doppler ultrasound examination of vasculature of selected organs such as kidneys may have a role in detection of hemodynamic rearrangements that occur in cases of placental insufficiency and preeclampsia.

Conditions

Interventions

TypeNameDescription
OTHERfetal ultrasound2D, 3D , Doppler ultrasound

Timeline

Start date
2023-11-01
Primary completion
2024-11-01
Completion
2024-12-31
First posted
2024-05-02
Last updated
2024-05-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06395974. Inclusion in this directory is not an endorsement.